Nanoveu’s cover photo
Nanoveu

Nanoveu

Nanotechnology Research

Singapore, Singapore 450 followers

Shaping Your Vision with Nanotechnology from EyeFly3D to Nanoshield, our Cuprous enriched antiviral & antibacterial film

About us

Nanoveu Limited is a Public Company listed on the Australian Stock Exchange (ASX: NVU), technology innovator that shapes vision through the power of modern and cutting-edge nanotechnology. Nano imprint science is applied to deliver vision-based applications that sets it apart from competitors. In the last year, we have developed Nanoshield, as a response to the SARS-CoV 2 pandemic. The range of products use a patented polymer of monovalent copper as the active ingredient in films, and other materials as a protection for surface transmission of pathogens. The film has been tested and verified independently by private and governmental agencies in several markets as a dependable (and constant) barrier to contact based viral and microbial germs. In 2019, Nanoveu developed a range of distinctive products pushing beyond the boundaries of innovation and will continue to create revolutionary products for change. such as EyeFly3D, the multi-award winning nano-engineered screen protector that turns the ordinary screens of handheld devices into 3D displays. We are constantly seeking new solutions and currently in development, have created EyeFyx - it nanotechnology to adjust digital images and text, allowing people that suffer from farsightedness (presbyopia) to view images on handheld screens without requiring reading glasses. We are always innovating, so please get in touch to see how we can help you, whether you are a facilities manager, looking for a peace of mind for high traffic venues against contact transmission, or simply a sample of our screen protectors that reduce the lifespan of viral and bacterial activity on touch screens, and mobile devices. We look forward to hearing from you. Visit our website for contact information.

Industry
Nanotechnology Research
Company size
11-50 employees
Headquarters
Singapore, Singapore
Type
Public Company
Founded
2018
Specialties
nanotechnology, antiviral, self-disinfecting film, Advanced manufacturing, screen protector, innovative vision products, optically clear film, nanoimprint technology, nanoimprint lithography, mobile phones, mobile devices, patents, cleaning solutions, Antimicrobial Copper, Antimicrobial , coating, facilities maanagement, and public health

Locations

Employees at Nanoveu

Updates

  • Exciting things happening at Nanoveu!

    View profile for Alfred Chong

    Founder & CEO of Nanoveu Limited (ASX: NVU)

    𝗡𝗮𝗻𝗼𝘃𝗲𝘂 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝘀 𝗘𝗠𝗔𝗦𝗦 𝗔𝗰𝗾𝘂𝗶𝘀𝗶𝘁𝗶𝗼𝗻 𝘁𝗼 𝗣𝗼𝘄𝗲𝗿 𝗔𝗜 & 𝟯𝗗 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 We are pleased to announce the 𝗳𝗶𝗻𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗼𝘂𝗿 𝗮𝗰𝗾𝘂𝗶𝘀𝗶𝘁𝗶𝗼𝗻 𝗼𝗳 𝗘𝗠𝗔𝗦𝗦, a significant step in strengthening Nanoveu’s capabilities in AI-driven System-on-a-Chip (SoC) technology. This move aligns with our long-term vision of 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗻𝗴 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗔𝗜 𝗶𝗻𝗳𝗿𝗮𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲 𝗶𝗻𝘁𝗼 𝗜𝗼𝗧 𝗱𝗲𝘃𝗶𝗰𝗲𝘀 𝗮𝗻𝗱 𝗲𝗱𝗴𝗲 𝗰𝗼𝗺𝗽𝘂𝘁𝗶𝗻𝗴. While EMASS’ 𝘂𝗹𝘁𝗿𝗮-𝗹𝗼𝘄-𝗽𝗼𝘄𝗲𝗿 𝗦𝗼𝗖𝘀 will enhance 𝗘𝘆𝗲𝗙𝗹𝘆𝟯𝗗™, enabling 𝗿𝗲𝗮𝗹-𝘁𝗶𝗺𝗲 𝟮𝗗-𝘁𝗼-𝟯𝗗 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗶𝗼𝗻𝘀 across a wider range of devices, their impact extends far beyond. These advanced semiconductor solutions provide a 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗳𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗔𝗜-𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗶𝗻𝗴 𝗶𝗻 𝗜𝗼𝗧, 𝘀𝗺𝗮𝗿𝘁 𝗵𝗼𝗺𝗲 𝗱𝗲𝘃𝗶𝗰𝗲𝘀, 𝘄𝗲𝗮𝗿𝗮𝗯𝗹𝗲𝘀, 𝗮𝗻𝗱 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗮𝗹 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗶𝗼𝗻. By leveraging this technology, we are expanding into 𝗻𝗲𝘄 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝘄𝗵𝗲𝗿𝗲 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝘆, 𝘀𝗰𝗮𝗹𝗮𝗯𝗶𝗹𝗶𝘁𝘆, 𝗮𝗻𝗱 𝗼𝗻-𝗱𝗲𝘃𝗶𝗰𝗲 𝗶𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝗮𝗿𝗲 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹.

Similar pages

Funding

Nanoveu 1 total round

Last Round

Post IPO equity
See more info on crunchbase